Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Hisse Senetlerindeki Sıralama #33721
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Hisse Fiyatı
$0.4732
Son senkronizasyon: 2022-10-26
Piyasa Değeri
$7.05M
Değişim (1 gün)
-0.03%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret GBS Inc. (GBS)

Kategori

GBS Inc. (GBS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.49 - 2022-10-01

Gün sonu en düşük fiyat: $9.14 - 2020-12-01
GBS Inc. için hisse fiyatı geçmişi: 2020 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2022 -69.81%
2021 -82.27%
2020 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US